SGVT vs. PBE

Last updated Jun 16, 2026

SGVT (Schwab Government Money Market ETF) and PBE (Invesco Dynamic Biotechnology & Genome ETF) are both exchange-traded funds - SGVT is a Money Market fund actively managed by Charles Schwab, while PBE is a Health & Biotech Equities fund tracking the Dynamic Biotech & Genome Intellidex Index (AMEX). SGVT is actively managed, while PBE is passively managed. Over the past year, SGVT returned 3.74% vs 34.13% for PBE. At a correlation of -0.01, they often move in opposite directions. SGVT charges 0.28%/yr vs 0.59%/yr for PBE.

Performance

SGVT vs. PBE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Schwab Government Money Market ETF (SGVT) and Invesco Dynamic Biotechnology & Genome ETF (PBE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SGVT achieves a 1.51% return, which is significantly lower than PBE's 3.32% return.

SGVT

• 1D: -0.01%
• 1M: 0.26%
• YTD: 1.51%
• 6M: 1.68%
• 1Y: 3.74%
• 3Y*: —
• 5Y*: —
• 10Y*: —

PBE

• 1D: 0.81%
• 1M: 4.85%
• YTD: 3.32%
• 6M: 5.17%
• 1Y: 34.13%
• 3Y*: 10.91%
• 5Y*: 2.31%
• 10Y*: 8.90%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SGVT vs. PBE - Yearly Performance Comparison

	2026 (YTD)	2025
SGVT Schwab Government Money Market ETF	1.51%	2.22%
PBE Invesco Dynamic Biotechnology & Genome ETF	3.32%	28.44%

Correlation

The correlation between SGVT and PBE is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.00
Correlation (All Time) Calculated using the full available price history since Jun 12, 2025	-0.01

Return for Risk

SGVT vs. PBE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SGVT

SGVT Risk / Return Rank: 100
SGVT Sharpe Ratio Rank: 100
SGVT Sortino Ratio Rank: 100
SGVT Omega Ratio Rank: 100
SGVT Calmar Ratio Rank: 100
SGVT Martin Ratio Rank: 100

PBE

PBE Risk / Return Rank: 58
PBE Sharpe Ratio Rank: 58
PBE Sortino Ratio Rank: 63
PBE Omega Ratio Rank: 53
PBE Calmar Ratio Rank: 63
PBE Martin Ratio Rank: 52

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SGVT vs. PBE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Schwab Government Money Market ETF (SGVT) and Invesco Dynamic Biotechnology & Genome ETF (PBE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SGVT	PBE	Difference
Sharpe ratio: Return per unit of total volatility	18.33	1.81	+16.52
Sortino ratio: Return per unit of downside risk	100.91	2.68	+98.22
Omega ratio: Gain probability vs. loss probability	36.10	1.31	+34.79
Calmar ratio: Return relative to maximum drawdown	138.97	2.92	+136.05
Martin ratio: Return relative to average drawdown	1,477.41	8.21	+1,469.20

SGVT vs. PBE - Sharpe Ratio Comparison

The current SGVT Sharpe Ratio is 18.33, which is higher than the PBE Sharpe Ratio of 1.81. The chart below compares the historical Sharpe Ratios of SGVT and PBE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

SGVT vs. PBE - Drawdown Comparison

The maximum SGVT drawdown since its inception was -0.03%, smaller than the maximum PBE drawdown of -45.69%. Use the drawdown chart below to compare losses from any high point for SGVT and PBE.

Drawdown Indicators

	SGVT	PBE	Difference
Max Drawdown Largest peak-to-trough decline	-0.03%	-45.69%	+45.66%
Max Drawdown (1Y) Largest decline over 1 year	-0.03%	-11.73%	+11.70%
Max Drawdown (3Y) Largest decline over 3 years	—	-22.43%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-34.71%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-37.84%	—
Current Drawdown Current decline from peak	-0.01%	-1.00%	+0.99%
Average Drawdown Average peak-to-trough decline	-0.00%	-16.21%	+16.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.00%	4.17%	-4.17%

Volatility

SGVT vs. PBE - Volatility Comparison

The current volatility for Schwab Government Money Market ETF (SGVT) is 0.07%, while Invesco Dynamic Biotechnology & Genome ETF (PBE) has a volatility of 6.04%. This indicates that SGVT experiences smaller price fluctuations and is considered to be less risky than PBE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SGVT	PBE	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.07%	6.04%	-5.97%
Volatility (6M) Calculated over the trailing 6-month period	0.13%	13.67%	-13.54%
Volatility (1Y) Calculated over the trailing 1-year period	0.21%	19.01%	-18.80%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.21%	22.48%	-22.27%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.21%	24.91%	-24.70%

SGVT vs. PBE - Expense Ratio Comparison

SGVT has a 0.28% expense ratio, which is lower than PBE's 0.59% expense ratio.

Dividends

SGVT vs. PBE - Dividend Comparison

SGVT's dividend yield for the trailing twelve months is around 3.12%, more than PBE's 1.02% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
PBE Invesco Dynamic Biotechnology & Genome ETF	1.02%	1.00%	0.05%	0.02%	0.00%	0.00%	0.04%	0.00%	0.00%	0.57%	0.38%	1.12%
SGVT Schwab Government Money Market ETF	3.12%	1.73%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both SGVT and PBE in my portfolio?

SGVT and PBE have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SGVT or PBE?

PBE has higher volatility (6.04%) compared to SGVT (0.07%). In terms of maximum drawdown, SGVT dropped -0.03% vs PBE's -45.69%.

Which ETF is better, SGVT or PBE?

On 1-year performance, PBE leads with 34.13% vs 3.74% for SGVT. On fees, SGVT is cheaper at 0.28% per year. On volatility, SGVT has been the lower-risk option at 0.07%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, SGVT or PBE?

Over the 1-year period, PBE has performed better with a 34.13% return vs 3.74%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, SGVT or PBE?

SGVT is cheaper with a 0.28% expense ratio, compared with 0.59% for PBE.

Which ETF pays a higher dividend yield, SGVT or PBE?

SGVT has the higher dividend yield at 3.12%, compared with 1.02% for PBE.

What is the main difference between SGVT and PBE?

SGVT is categorized as Money Market, while PBE is Health & Biotech Equities. They also come from different issuers: Charles Schwab and Invesco. Their fees differ too: 0.28% for SGVT and 0.59% for PBE.

Which has better risk-adjusted returns?

SGVT currently has the higher Sharpe Ratio (18.33 vs 1.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.